1. Home
  2. FOA vs CMPX Comparison

FOA vs CMPX Comparison

Compare FOA & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finance of America Companies Inc.

FOA

Finance of America Companies Inc.

HOLD

Current Price

$14.17

Market Cap

221.6M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.87

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOA
CMPX
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.6M
408.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FOA
CMPX
Price
$14.17
$1.87
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$26.00
$14.57
AVG Volume (30 Days)
53.4K
2.3M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
216.95
N/A
EPS
0.41
N/A
Revenue
$497,432,000.00
N/A
Revenue This Year
$0.58
N/A
Revenue Next Year
$6.91
$934.41
P/E Ratio
$35.24
N/A
Revenue Growth
47.09
N/A
52 Week Low
$14.40
$1.61
52 Week High
$29.79
$6.88

Technical Indicators

Market Signals
Indicator
FOA
CMPX
Relative Strength Index (RSI) 14.94 32.08
Support Level N/A $1.75
Resistance Level $20.17 $2.18
Average True Range (ATR) 0.64 0.11
MACD -0.14 -0.06
Stochastic Oscillator 3.37 5.30

Price Performance

Historical Comparison
FOA
CMPX

About FOA Finance of America Companies Inc.

Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: